PlanetRx: Drugs & Perfume.com
Executive SummaryAlthough only six-months old, the cyber drugstore industry has generated considerable publicity and made a big impression on investors. Three major players--PlanetRx.com., drugstore.com & Soma.com-- have emerged thus far, and are engaged in a furious battle to quickly gain market share. The first major hurdle that these companies must clear is signing on third party payers, many of which own or have exclusive relationships with mail order prescription services. But the biggest challenge facing PlanetRx and its competitors is to establish themselves as partners in Web-based networks which link them with providers, third party payers and other health care influencers.
You may also be interested in...
The $9.7bn acquisition hinges on the small interfering RNA inclisiran, but an ongoing cardiovascular outcomes trial, manufacturing hurdles, and reimbursement challenges provide subjects for concern.
US congressional leaders and medtech industry advocacy group AdvaMed are giving their full-throated endorsement to a US-Mexico-Canada (USMCA) trade agreement announced by the US Trade Representative's Office on 10 December. See what AdvaMed's president and CEO, Scott Whitaker, said about it in a statement here.
FDA seems poised to approve the drug for the orphan eye disease called TED, but remains concerned about labeling for some adverse events.